Fetomaternal hemorrhage.
Fetomaternal hemorrhage refers to the entry of fetal blood into the maternal circulation before or during delivery. Antenatal fetomaternal hemorrhage is a pathological condition with a wide spectrum of clinical variation. Secondary to the resultant anemia, fetomaternal hemorrhage may have devastating consequences for the fetus such as neurologic injury, stillbirth, or neonatal death. Presentation is frequently without an evident precipitating factor. Recognition may become apparent only after injury has occurred, if at all. The most common antenatal presentation is decreased fetal activity and a heightened index of suspicion is warranted in cases of persistent maternal perception of decreased fetal movements. The diagnostic standard, the Kleihauer-Betke screen, has several limitations. Management remains challenging. When detected antenatally, cordocentesis with intrauterine transfusion may be attempted to correct the anemia; however, repeat intrauterine transfusion or delivery may be necessitated to correct ongoing bleeding. Although the occurrence of large antenatal fetomaternal hemorrhage is fortunately rare, this entity likely remains underreported and underrecognized. A national registry should be created to advance our learning across institutions by reviewing the clinical presentations of fetomaternal hemorrhage, the variety of fetal heart rate tracings observed, the management strategies undertaken, and the outcomes achieved.
Wylie
Blair J
BJ
From the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts; and the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York.
D'Alton
Mary E
ME
D000818:Animals; D005260:Female; D005331:Fetomaternal Transfusion / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D005434:Flow Cytometry; D006801:Humans; D011247:Pregnancy; D011256:Pregnancy Outcome; D011379:Prognosis
Dienst A. Zentrabl Gynakol 1905;29:353.
Wiener AS. Diagnosis and treatment of anemia of the newborn caused by occult placental hemorrhage. Am J Obstet Gynecol 1948;56:717–22.
Chown B. Anemia from bleeding of the fetus into the mother's circulation. Lancet 1954;266:1213–5.
Chown B. The fetus can bleed; three clinicopathological pictures. Am J Obstet Gynecol 1955;70:1298–308.
Cregar WP, Steele MR. Fetomaternal transfusion. N Engl J Med 1957;256:158.
Grimes HG, Wright FS. Fetomaternal transfusion. A case report. Am J Obstet Gynecol 1961;82:1371–4.
Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117–21.
Medearis AL, Hensleigh PA, Parks DR, Herzenberg LA. Detection of fetal erythrocytes in maternal blood post partum with fluorescence-activated cell sorter. Am J Obstet Gynecol 1984;148:290–5.
Sebring ES, Polesky HF. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion 1990;30:344–57.
Pollack W, Ascari WQ, Kochesky RJ, O'Connor RR, Ho Ty, Tripodi D. Studies on Rh prophylaxis. 1. Relationship between dose of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333–9.
Rubod C, Deruelle P, Le Goueff F, Tunez V, Fournier M, Subtil D. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol 2007;110:256–60.
De Almeida V, Bowman JM. Massive fetomaternal hemorrhage: Manitoba experience. Obstet Gynecol 1994;83:323–8.
Nicolaides KH, Clewell WH, Rodeck CH. Measurement of human fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet Gynecol 1987;157:50–3.
Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III, Hankins GDV, et al. Williams obstetrics. 20th ed. Stamford (CT): Appleton & Lange; 1997.
Fay RA. Feto-maternal haemorrhage as a cause of fetal morbidity and mortality. Br J Obstet Gynaecol 1983;90:443–6.
Queenan JT, Landesman R, Nakamoto M, Wilson KH. Postpartum immunization: report of a study. Obstet Gynecol 1962;20:774–80.
Adams KM, Nelson JL. Microchimerism: An investigative frontier in autoimmunity and transplantation. JAMA 2004;291:1127–31.
Bianchi DW. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract Res Clin Obstet Gynaecol 2004;18:959–75.
Nord E, Blaschke E, Green K, Thomassen P. 100 cases of external cephalic version, with special reference to fetomaternal transfusion. Acta Obstet Gynecol Scand 1989;68:55–8.
Bickers RG, Wennberg RP. Fetomaternal transfusion following trauma. Obstet Gynecol 1983;61:258–9.
Rose PG, Strohm PL, Zuspan FP. Fetomaternal hemorrhage following trauma. Am J Obstet Gynecol 1985;153:844–7.
Queenan JT, Nakamoto M. Postpartum immunization: the hypothetical hazard of manual removal of the placenta. Obstet Gynecol 1964;23:392–5.
Cardwell MS. Ultrasound diagnosis of abruption placentae with fetomaternal hemorrhage. Am J Obstet Gynecol 1987;157:358–9.
Verco CH, Jones WR. Monoamniotic twin pregnancy complicated by massive fetal-maternal haemorrhage. Aust NZ J Obstet Gynaecol 1981;21:186–7.
Christensen J. Haemoglobin-F. Serological conditions and occurrence in normal adults and normal pregnant and post partum women with particular reference to foeto-maternal hemorrhage. Dan Med Bull 1968;15:166–74.
Sims DG, Barron SL, Wadehra V, Ellis HA. Massive chronic feto-maternal bleeding associated with placental chorioangiomas. Acta Paediatr Scand 1976;65:271–3.
Santamaria M, Benirschke K, Carpenter PM, Baldwin VJ, Pritchard JA. Transplacental hemorrhage associated with placental neoplasms. Pediatr Pathol 1987;7:601–15.
Queenan JT, Adams DA. Amniocentesis: a possible immunizing hazard. Obstet Gynecol 1964;24:530–3.
Bowman JM, Pollock JM. Transplacental fetal hemorrhage after amniocentesis. Obstet Gynecol 1985;66:749–54.
Devi B, Jennison RF, Langley FA. Significance of placental pathology in transplacental hemorrhage. J Clin Pathol 1968;21:322–31.
Giacoia GP. Severe fetomaternal hemorrhage: a review. Obstet Gynecol Surv 1997;52:372–80.
Laube DW, Schauberger CW. Fetomaternal bleeding as a cause for “unexplained” fetal death. Obstet Gynecol 1982;60:649–51.
Samadi R, Greenspoon JS, Gviazda I, Settlage RH, Goodwin TM. Massive fetomaternal hemorrhage and fetal death: are they predictable? J Perinatol 1999;19:227–9.
Stedman CM, Baudin JC, Unile CA, Cooper ES. Use of the erythrocyte rosette test to screen for excessive fetomaternal hemorrhage in Rh-negative women. Am J Obstet Gynecol 1986;154:1363–9.
Kleihauer B, Braun H, Betke K. [Demonstration of fetal hemoglobin in erythrocytes of a blood smear.] Klin Wochenschr 1957;35:637–8.
Polesky HF, Sebring ES. Evaluation of methods for detection and quantitation of fetal cells and their effect on RhIG usage. Am J Clin Pathol 1981;76:525–9.
Duckett JR, Constatine G. The Kleihauer technique: an accurate method of quantifying fetomaternal hemorrhage? Br J Obstet Gynecol 1997;103:845–6.
Warzynski MJ. A flow cytometric “hemoglobin F” test to replace the Kleihauer-Betke slide test: background and practical considerations for implementation. AML Interact 1999;4:1–2.
McPherson RA, Pincus MR. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia (PA): WB Saunders Company; 2006.
Wood WG, Stamatoyannopoulos G, Lim G, Nute PE. F-cell in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. Blood 1975;46:671–82.
Pembrey ME, Weatherall DJ, Clegg JB. Maternal synthesis of haemoglobin F in pregnancy. Lancet 1973;1:1350–4.
Popat N, Wood WG, Weatherall DJ, Turnbull AC. Pattern of maternal F-cell production during pregnancy. Lancet 1977;2:377–9.
Dziegiel MH, Nielsen LK, Berkowicz A. Detecting fetomaternal hemorrhage by flow cytometry. Curr Opin Hematol 2006;13:490–5.
Davis BH, Olsen S, Bigelow NC, Chen JC. Detection of fetal red cells in fetomaternal hemorrhage using a fetal hemoglobin monoclonal antibody by flow cytometry. Transfusion 1998;38:749–56.
Chen JC, Bigelelow NC, Davis BH. Proposed flow cytometric reference method for the determination of erythroid F-cell counts. Cytometry 2000;42:239–46.
Porra V, Bernaud J, Gueret P, Bricca P, Rigal D, Follea G, et al. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit. Transfusion 2007;47:1281–9.
Chen JC, Davis BH, Wood B, Warzynski J. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002;50:285–90.
Transfusion Medicine Resource Committee. Surveys 2006. HBF-B. Fetal RBC detection. Participant summary. Northfield (IL): College of American Pathologists; 2006.
Lund CJ, Donovan JC. Blood volume during pregnancy: significance of plasma and red cell volumes. Am J Obstet Gynecol 1967;98:394–403.
Romano EL, Mollison PL, Linares J. Number of B sites generated on group O red cells from adults and newborn infants. Vox Sang 1978;34:14–7.
Roberts DJ. Placental pathology, a survival guide. Arch Pathol Lab Med 2008;132:641–51.
Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol 2008;l 112(3):661–6.
Moise KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol 2008;161:e1–4.
Zimmerman R, Carpenter RJ Jr, Durig P, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG 2002;109:746–52.
Corston JM, Morton BS, Robinson SC. Intrauterine blood transfusion of the fetus. Can Med Assoc J 1964;91:815–7.
Queenan JT, Douglas RG. Intrauterine transfusion: a preliminary report. Obstet Gynecol 1965;25:308–21.
Rubod C, Houfflin V, Belot F, Ardiet E, Dufour P, Subtil D, et al. Successful in utero treatment of chronic and massive fetomaternal hemorrhage with fetal hydrops. Fetal Diagn Ther 2006;21:410–3.
Tannirandorn Y, Nicolini U, Nicolaidis P, Nasrat H, Letsky EA, Rodeck CH. Intrauterine death due to fetomaternal hemorrhage despite successful treatment of fetal anemia. J Perinat Med 1990;18:233–5.
Detti L, Oz U, Guney I, Ferguson JE, Bahado-Singh RO, Mari G. Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 2001;185:1048–51.
Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. Am J Obstet Gynecol 2006;195:1550–6.
Catalano PM, Capeless EL. Fetomaternal bleeding as a cause of recurrent fetal morbidity and mortality. Obstet Gynecol 1990;76:972–3.
Dupont G, Povlsen JV. [Repeated episodes of fetomaternal hemorrhage in the same woman]. Ugeskr Laeger 1991;153:2750.
Maass B, Würfel B, Fusch C. Recurrent fetomaternal transfusion in two consecutive pregnancies. Prenat Diagn 2001;21:791–3.
Parveen V, Patole SK, Whitehall JS. Massive fetomaternal hemorrhage with persistent pulmonary hypertension in a neonate. Indian Pediatr 2002;39:385–8.
Naeslund J, Nylin G. Investigation of permeability of placenta with aid of red corpuscles tagged with radioactive phosphorus. Acta Med Scandinav 1946;170:390.
Mengert WF, Rights CS, Bates CR Jr, Reid AF, Wolf GR, Nabor GC. Placental transmission of erythrocytes. Am J Obstet Gynecol 1955;69:678–85.
Macris NT, Hellman LM, Watson RJ. The transmission of transfused sickle-trait cells from mother to fetus. Am J Obstet Gynecol 1958;76:1214–8.
Brace RA, Cheung CY. Fetal blood volume restoration following a rapid fetal hemorrhage. Am J Physiol 1990;259:H567–73.
Brace RA. Mechanisms of fetal blood volume restoration after slow fetal hemorrhage. Am J Physiol 1989;256:R1040–3.
Brace RA, Cheung CY. Fetal blood volume restoration following rapid fetal hemorrhage. Am J Physiol 1990;259:H567–73.
Gruslin-Giroux A, Shields LA, Widness JA, Brace RA. Fetal plasma iron and restoration of red blood cell mass after hemorrhage of the ovine fetus. Am J Obstet Gynecol 1997;177:1172–7.
Miura K, Yoshiura K, Miura S, Yamasaki K, Nakayama D, Ishimaru T, et al. Cell-free DNA is more sensitive than cell-free mRNA as a marker for evaluation of fetal-maternal hemorrhage. Clin Chem 2006;52:2121–3.
Clark SL, Hankins GDV, Dudley DA, Dildey GA, Porter TF. Amniotic fluid embolism: analysis of a National Registry. Am J Obstet Gynecol 1995;172:1158–69.
Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC III, Hankins GDV, et al. Williams obstetrics. 20th ed. Stamford (CT): Appleton & Lange; 1997. p. 982.
Kleihauer E. Beihefte zum. Arch Kinderheilk 1966;53:234–5.
Creasy RK, Resnik R, Iams JD, editors. Maternal-fetal medicine. 5th ed. Philadelphia (PA): Saunders 2004. p. 541.
Foley MR, Strong TH Jr, Garite T, editors. Obstetric intensive care manual. 2nd ed. New York (NY): McGraw-Hill Medical Publishing Division; 2004. p. 239.
Fisher R, Kuhlman K, Grover J, Montgomery O, Wapner R. Chronic, massive fetomaternal hemorrhage treated with repeated fetal intravascular transfusions. Am J Obstet Gynecol 1990;162:203–4.
Elliot J. Massive fetomaternal hemorrhage treated by fetal intravascular transfusion. Obstet Gynecol 1991;78:520–3.
Cardwell M. Successful treatment of hydrops fetalis caused by fetomaternal hemorrhage: a case report. Am J Obstet Gynecol 1998;158:131–2.
Thorp JA, Cohen GR, Yeast JD, Perryman D, Welsh C, Honssinger N, et al. Nonimmune hydrops caused by massive fetomaternal hemorrhage and treated by intravascular transfusion. Am J Perinatol 1992;9:22–4.
Rouse D, Weiner C. Ongoing fetomaternal hemorrhage treated by serial fetal intravascular transfusions. Obstet Gynecol 1990;76:974–5.
Kohlenberg C, Ellwood D. Fetomaternal haemorrhage treated with intravascular transfusion: a late complication of amniocentesis. Br J Obstet Gynecol 1994;101:912–3.
Montgomery L, Belfort M, Adam K. Massive fetomaternal hemorrhage treated with serial combined intravascular and intraperitoneal fetal transfusions. Am J Obstet Gynecol 1995;173:234–5.
Hartung J, Chaoui R, Bollmann R. Nonimmune hydrops from fetomaternal hemorrhage treated with serial fetal intravascular transfusion. Obstet Gynecol 2000;96:844.
Lipitz S, Achiron R, Horoshovski D, Rotstein Z, Sherman D, Schiff E. Fetomaternal haemorrhage discovered after trauma and treated by fetal intravascular transfusion. Eur J Obstet Gynecol Reprod Biol 1997;71:21–2.
Weisberg L, Kingdom J, Keating S, Ryan G, Seaward G, Kelly E, et al. Treatment options in fetomaternal hemorrhage: four case studies. J Obstet Gynaecol Can 2004;26:893–8.